NextCure
2 known investors
Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
Biotech
Investors · 2
In the news
- H.C. Wainwright reiterates NextCure stock rating on merger news By Investing.cominvesting.com · 2026
- NextCure backs Avere merger with $320 million financing | Grafagrafa.com · 2026
- NextCure (NASDAQ: NXTC) sets Avere merger backed by $320M raisestocktitan.net · 2026
- NextCure and Avere Merger Signals Ambitious Push Toward...marketchameleon.com · 2026